期刊文献+

中西医结合对三阴乳腺癌患者的生存率影响研究 被引量:10

A study on the effect of Integrative medicine on survival rate of patients with triple-negative breast cancer
下载PDF
导出
摘要 目的研究辨证服用中药对三阴乳腺癌病患生存率的影响。方法自2010年2月到2013年11月,于该院中医部选取术后被确诊为三阴乳腺癌患者98例,以数字法随机分成观察组(50例)和对照组(48例)。观察组在术后辨证服用中药联合西药治疗,对照组施以单纯的西药治疗。观察组患者服用中药的时间至少达1年;对照组患者按照美国西医指导标准对三阴乳腺癌患者进行治疗。结果观察组无病生存者占比88.00%(44/50),总生存率为98.00%(49/50),均显著高于对照组的66.67%(32/48),83.33%(40/48),差异均有统计学意义(均P<0.05)。结论三阴乳腺癌病患通过辨证口服中药能有效提高患者无病生存率及总生存率,减少复发转移率,延长生存期。 Objective To investigate the effect of traditional Chinese medicine on survival rate of patients with triple -negative breast cancer ( TNBC) .Methods We randomized 98 patients with TNBC , who were diagnosed after surgery in Department of Traditional Chinese Medicine in Beijing Military Region General Hospital between February 2010 and November 2013, into observation group (50 patients) and control group (48 patients) .Traditional Chinese medicine combined with western medicine were provided in observation group, while western medicine only was offered in control group .Traditional Chinese medicine was taken for at least one year in obser-vation group , and the patients with TNBC in control group were treated according to American medicine guidelines .Results Disease-free survival rate and overall survival rate in observation group reached 88.00%(44/50) and 98.00%(49/50), respectively, which were significantly higher than 66.67%(32/48) and 83.33%(40/48) in control group, respectively, and the difference was significant (P〈0.05).Conclusions Disease-free survival rate and overall survival rate were increased in TNBC patients who administrated tra-ditional Chinese medicine , with reduction of recurrence and metastasis rate and prolongation of survival .
出处 《安徽医药》 CAS 2014年第9期1757-1758,共2页 Anhui Medical and Pharmaceutical Journal
关键词 中药 三阴乳腺癌 生存率 影响 traditional Chinese medicine triple-negative breast cancer survival rate effect
  • 相关文献

参考文献12

二级参考文献72

  • 1陈国英.乳腺癌根治术后腋窝处切口感染的分析[J].河南外科学杂志,2009,15(2). 被引量:4
  • 2田金洲,王永炎,时晶,朱爱华,张伯礼,黄启福.证候的概念及其属性[J].北京中医药大学学报,2005,28(5):6-8. 被引量:52
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4周志清,李新苹,董军.乳腺癌68例治疗体会[J].中国厂矿医学,2007,20(4):382-383. 被引量:2
  • 5Bauer KR,Brown M,Cress RD,et al.Descriptive analysis of estrogen receptor(ER)negative,progesterone receptor(PR)negative,and HER-2 negative invasive breast cancer,the so-called triple-negative phenotype:a population-based study from the California cancer Registry[J].Cancer,2007,109(9):1721.
  • 6Yi S,Uhm J,Cho E,et al.Clinical outcomes of metastatic breast cancer patients with triple-negative phenotype who received platinum-containing chemotherapy[J].J Clin Oncol,2008,26:1008.
  • 7Miller K,Wang M,Gralow J,et al.Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer[J].N Engl J Med,2007,357(26):2666-76.
  • 8Zelek L,Barthier S,Riofrio M,et al.Weekly vinorelbine is an effective palliative regimen after failure with anthracyclines and taxanes in metastatic breast carcinoma[J].Cancer,2001,92(9):2267-72.
  • 9Decatris MP,Sunder S,O Byrne KJ,et al.Platinum-based chemotherapy in metastatic breast cancer:current status[J].Cancer Trert Rev,2004,30(1):53-81.
  • 10周际昌.实用肿瘤内科学[M].2版.北京:人民卫生出版社,2005:92-94.

共引文献536

同被引文献135

引证文献10

二级引证文献68

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部